Delivery Order SPE2DB20D2014-SPE2DB25FA88U

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $24,700.91 firm fixed-price delivery order is for the medical product CAPLYTA 21 MG CAPSULE 30S. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,865.91 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG capsules. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,145.85 firm-fixed price delivery order is for the supply of CAPLYTA 42 MG capsules. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,337.17 Firm Fixed Price Delivery Order contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,576.72, is a delivery order contract with a firm fixed price pricing type. The contract covers the supply of CAPLYTA 42 MG CAPSULE 30S, a medical product, with a period of performance through January 31, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $1,067.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 7, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, and there is no set-aside designation noted. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order valued at $6,920.87 issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The order is for the pharmaceutical product CAPLYTA 42 MG CAPSULE 30S, with a completion date of December 6, 2024. Amerisourcebergen, a major pharmaceutical distributor registered in the System for Award Management (SAM.gov), has established itself as a key vendor for federal healthcare programs, particularly within military and...
This federal contract award, valued at $4,819.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a Firm Fixed Price agreement. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $25,851.61 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The award has a completion date of February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, as well as an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,023.73, is for the delivery of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is May 2, 2024. This contract award is not associated...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA88U
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,208.02 firm-fixed-price delivery order is for CAPLYTA 21 MG CAPSULE 30S, with a completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated as a set-aside.

Generated 5/4/25, 12:53 AM